Instituto Murciano Of Investigacion Biosanitaria Virgen Of La Arrixaca Imib

Murcia, Spain

Instituto Murciano Of Investigacion Biosanitaria Virgen Of La Arrixaca Imib

Murcia, Spain
SEARCH FILTERS
Time filter
Source Type

Esteve-Pastor M.A.,University of Murcia | Esteve-Pastor M.A.,Instituto Murciano Of Investigacion Biosanitaria Virgen Of La Arrixaca Imib | Roldan V.,Instituto Murciano Of Investigacion Biosanitaria Virgen Of La Arrixaca Imib | Roldan V.,University of Murcia | And 6 more authors.
Expert Review of Cardiovascular Therapy | Year: 2016

Oral anticoagulation therapy is essential in patients with atrial fibrillation and clinicians need guidance on decision-making between the vitamin K antagonists (VKA), e.g. warfarin, or non-vitamin K antagonist oral anticoagulants. Observational studies have shown that patients who receive VKA therapy spend a significant percentage of their time with international normalized ratio values outside of the therapeutic range (time in therapeutic range, TTR <60%.) Recently, a clinical score has been developed with commonly encountered clinical features, the SAMe-TT2R2 score, to help decision-making with regard to whether a patient is likely to do well, or not, with a VKA. Those with a SAMe-TT2R2 score of 0-1 are likely to do well on a VKA, while those with a SAMe-TT2R2 score ≥2 are on probability going to achieve suboptimal TTR. In this article, we provide an overview of the main published retrospective and prospective studies that have validated the SAMe-TT2R2 score and its value for decision-making in daily clinical practice. © 2015 Taylor & Francis.

Loading Instituto Murciano Of Investigacion Biosanitaria Virgen Of La Arrixaca Imib collaborators
Loading Instituto Murciano Of Investigacion Biosanitaria Virgen Of La Arrixaca Imib collaborators